Szpital Kliniczny Mswia Z Warmisko Mazurskim Centrum Onkologii

Olsztyn 10-228

2 studies enrolling now · 4 studies all time

What they study most

B-cell Lymphoma, B-cell Malignancy, Chronic Lymphocytic Leukemia, Esophageal Squamous Cell Carcinoma, Non-small Cell Lung Cancer (NSCLC), Refractory Cancer, Relapsed Cancer, Small Lymphocytic Lymphoma

Studies at this site

• A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma — Recruiting now
• A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies — Recruiting now
• A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy — Running, not enrolling
• A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) — Completed